- $567.78bn
- $573.16bn
- $32.65bn
- 99
- 15
- 82
- 71
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22,977 | 21,846 | 24,105 | 29,310 | 32,653 |
Cost of Revenue | |||||
Gross Profit | 18,812 | 17,334 | 19,135 | 23,602 | 26,086 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7,976 | 7,765 | 8,301 | 10,497 | 11,653 |
Operating Profit | 15,001 | 14,081 | 15,804 | 18,813 | 21,000 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 14,884 | 13,790 | 16,063 | 18,136 | 21,037 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12,080 | 10,866 | 12,311 | 14,957 | 17,273 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 12,080 | 10,866 | 12,311 | 14,957 | 17,273 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 12,080 | 10,866 | 12,311 | 14,957 | 17,273 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.46 | 4.9 | 5.69 | 7.53 | 7.2 |
Dividends per Share |